Search

DE-202026001211-U1 - Multi-layer system for the irreversible deactivation of anesthetic drug residues in a case-specific disposal container

DE202026001211U1DE 202026001211 U1DE202026001211 U1DE 202026001211U1DE-202026001211-U1

Abstract

(Main claim) Disposal container for the irreversible deactivation of anesthetic drug residues, comprising a multi-layered binding system arranged from top to bottom and including: 1. an upper layer of adsorbent and/or ion exchange resin, 2. a middle layer of activated carbon or another adsorption matrix, 3. a lower layer of a polymer gel for solidifying residual liquids, the layers are designed in such a way that propofol, opioids and ketamine are bound and solidified sequentially, and recovery of the active ingredients is impossible.

Assignees

  • KAMPMEIER TIM GERALD

Dates

Publication Date
20260513
Application Date
20260318
Priority Date
20260318

Claims (7)

  1. (Main claim) Disposal container for the irreversible deactivation of anesthetic drug residues, comprising a multi-layered binding system arranged from top to bottom and comprising: 1. an upper layer of adsorbent and/or ion exchange resin, 2. a middle layer of activated carbon or another adsorption matrix, 3. A lower layer of a polymer gel for solidifying residual liquids, wherein the layers are designed such that propofol, opioids and ketamine are bound and solidified sequentially and recovery of the active substances is excluded.
  2. Containers after Claim 1 , characterized in that the filling opening includes a non-return valve or a valve system.
  3. Containers after Claim 1 or 2 characterized by the fact that a case-related documentation interface is provided in the form of a QR code, RFID tag or serial number.
  4. Container according to one of the preceding claims, characterized in that the lower layer completely solidifies the introduced volume of liquid.
  5. Container according to one of the preceding claims, characterized in that the upper layer irreversibly binds basic active ingredients by ion exchange.
  6. Container according to one of the preceding claims, characterized in that the container is designed as a case-specific disposable product.
  7. Container according to one of the preceding claims, characterized in that a level indicator or a saturation indicator is provided.

Description

Technical field The invention relates to the safe disposal of residual quantities of liquid anesthetic drugs in clinical working environments, particularly in anesthesia. It includes a disposal container with a multi-layered binding system for the irreversible deactivation of propofol, opioids, ketamine, and other drugs. Initial situation and problem statement In clinical anesthesia, residual amounts of the following substances are generated after almost every procedure: • Propofol (lipophilic emulsion, risk of abuse, environmentally harmful) • Opioids (controlled substances, risk of abuse) • Ketamine (risk of abuse) • Benzodiazepines • Etomidate Currently, no systems exist that: • Safely deactivate propofol, opioids, and ketamine simultaneously • ensure irreversible bonding, • can be used on a case-by-case basis in the operating room workflow, • and integrate a controlled substances documentation interface. Object of the invention The object of the invention is to provide a system that: • Irreversibly binds residual amounts of typical anesthetic drugs, • can be used in a case-specific and workflow-compatible manner, • enables safe one-handed disposal, • and allows for unambiguous documentation assignment. Solution to the task The task is solved by a waste container with a multi-layered binding agent system, which is structured from top to bottom as follows: (1) Top layer: Adsorber / ion exchange resin • Primary contact with incoming liquid • Binding of basic active substances (opioids, ketamine) • Adsorption of lipophilic components • High permeability to subsequent liquid (2) Middle layer: Activated carbon / Adsorption matrix • Adsorption of lipophilic substances, especially propofol • Buffer zone for additional drug binding (3) Lower layer: Polymer gel / solidifier • Absorption and solidification of residual liquid • End barrier against leakage • Ensuring irreversibility The container also includes: • a filling opening with backflow preventer, • a case-related documentation interface (QR code, RFID, serial number), • a fill level indicator, • and an end lock after saturation. Advantages of the invention • Simultaneous deactivation of propofol, opioids and ketamine• Irreversible bonding through a combination of adsorption, ion exchange, and solidification• No recovery of the active ingredients• Case-related assignment in the controlled substances workflow• One-handed operation in the operating room setting• Minimizing microbial risks• Safe disposal without additional equipment